| Brianna Bayer, MD | |
|
1304 Pittsburgh St, Cheswick, PA 15024-1447 | |
| (724) 274-9797 | |
| Not Available |
| Full Name | Brianna Bayer |
|---|---|
| Gender | Female |
| Speciality | Family Practice |
| Experience | 10 Years |
| Location | 1304 Pittsburgh St, Cheswick, Pennsylvania |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1841619616 | NPI | - | NPPES |
| 14103638 | Other | CAQH |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | MD461802 (Pennsylvania) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Allegheny Valley Hospital | Natrona, PA | Hospital |
| Allegheny General Hospital | Pittsburgh, PA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Allegheny Clinic | 5395649586 | 1941 |
News Archive
The language that doctors use with low-income, rural patients can help determine whether these patients agree to participate in clinical trials testing new cancer treatments, a new study found.
Tibotec Pharmaceuticals Ltd. has announced the submission of a New Drug Application to the U.S. Food and Drug Administration (FDA) for TMC125 (etravirine), an investigational non- nucleoside reverse transcriptase inhibitor (NNRTI), being studied for use with other antiretroviral (ARV) agents as a treatment for people infected with HIV- 1.
Hikma Pharmaceuticals PLC, the fast growing multinational pharmaceutical group, today notes that Takeda Pharmaceuticals U.S.A. Inc. has been unsuccessful in appealing the decision by the United States District Court for the District of Delaware to deny Takeda's motion for a preliminary injunction in relation to the distribution of Hikma's colchicine 0.6mg capsules for the prophylaxis of gout flares in adults.
Magnetic stimulation of the posterior parietal cortex increases functional connectivity of a neural network implicated in memory, shows human research published in eNeuro.
› Verified 9 days ago
| Entity Name | Allegheny Clinic |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1073081493 PECOS PAC ID: 5395649586 Enrollment ID: O20040310000602 |
News Archive
The language that doctors use with low-income, rural patients can help determine whether these patients agree to participate in clinical trials testing new cancer treatments, a new study found.
Tibotec Pharmaceuticals Ltd. has announced the submission of a New Drug Application to the U.S. Food and Drug Administration (FDA) for TMC125 (etravirine), an investigational non- nucleoside reverse transcriptase inhibitor (NNRTI), being studied for use with other antiretroviral (ARV) agents as a treatment for people infected with HIV- 1.
Hikma Pharmaceuticals PLC, the fast growing multinational pharmaceutical group, today notes that Takeda Pharmaceuticals U.S.A. Inc. has been unsuccessful in appealing the decision by the United States District Court for the District of Delaware to deny Takeda's motion for a preliminary injunction in relation to the distribution of Hikma's colchicine 0.6mg capsules for the prophylaxis of gout flares in adults.
Magnetic stimulation of the posterior parietal cortex increases functional connectivity of a neural network implicated in memory, shows human research published in eNeuro.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Brianna Bayer, MD 1304 Pittsburgh St, Cheswick, PA 15024-1447 Ph: (724) 274-9797 | Brianna Bayer, MD 1304 Pittsburgh St, Cheswick, PA 15024-1447 Ph: (724) 274-9797 |
News Archive
The language that doctors use with low-income, rural patients can help determine whether these patients agree to participate in clinical trials testing new cancer treatments, a new study found.
Tibotec Pharmaceuticals Ltd. has announced the submission of a New Drug Application to the U.S. Food and Drug Administration (FDA) for TMC125 (etravirine), an investigational non- nucleoside reverse transcriptase inhibitor (NNRTI), being studied for use with other antiretroviral (ARV) agents as a treatment for people infected with HIV- 1.
Hikma Pharmaceuticals PLC, the fast growing multinational pharmaceutical group, today notes that Takeda Pharmaceuticals U.S.A. Inc. has been unsuccessful in appealing the decision by the United States District Court for the District of Delaware to deny Takeda's motion for a preliminary injunction in relation to the distribution of Hikma's colchicine 0.6mg capsules for the prophylaxis of gout flares in adults.
Magnetic stimulation of the posterior parietal cortex increases functional connectivity of a neural network implicated in memory, shows human research published in eNeuro.
› Verified 9 days ago
Timothy Martin, Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 221 Russellton Dorseyville Rd, Upmc St Margaret Hospital, Cheswick, PA 15024 Phone: 412-767-5387 | |
Paul Brayer, Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 928 Route 910, Valley Family Medicine-upmc, Emmerling Plaza, Cheswick, PA 15024 Phone: 412-767-4751 |